- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
NEW YORK, N.Y., USA: Dental implant surgery procedures can conflict with the medication needs of heart patients. A less invasive approach to dental implants offers heart patients a better surgical and postsurgical experience. It allows the patient to undergo the procedure without interruption of long-term anticoagulant medication. The Journal of Oral Implantology presents two cases in which a flapless surgical technique was used rather than conventional implant techniques.
In the flapless technique, implants are drilled directly through the soft tissue into the bone. This study assessed the potential of the modified procedure to reduce bleeding, surgery time, postoperative pain, and soft tissue inflammation.
For patients with prosthetic heart valves, deep vein thrombosis, and other heart conditions, lifelong oral anticoagulant therapy is often prescribed. Warfarin is a commonly prescribed anticoagulant that reduces the risk of thromboembolism. Whether warfarin should be discontinued before dental procedures has been a subject of debate — is the risk of thromboembolism when an anticoagulant is withdrawn a greater threat than the risk of bleeding if it is continued?
In this study, the minimally invasive flapless implant technique was used for two heart patients — a 45-year-old woman and a 58-year-old man. Both patients continued their warfarin therapy without interruption. After implant surgery, the patients were monitored for 30 minutes, and subsequent examinations took place one week, five weeks and six months after the operation. Both patients showed good healing, minimal inflammation, and no abnormalities. No signs of bleeding were present in their follow-up exams.
The authors of this study propose designating this technique the “WarLess procedure” — incorporating “warfarin” and “flapless.” This preliminary study shows that flapless dental implant surgery can be safe and effective for patients without interruption of anticoagulant medication. Larger clinical trials are needed to confirm the safety of the technique on a broader scale.
Full text of the article, “Flapless Dental Implant Surgery for Patients on Oral Anticoagulants — The ‘WarLess Procedure’: A Report of 2 Cases,” was published in the Journal of Oral Implantology, Vol. 39, Special Issue, 2013, It is available online at www.joionline.org/doi/full/10.1563/AAID-JOI-D-11-00105.
(Source: Journal of Oral Implantology)
Mon. 29 April 2024
12:30 PM EST (New York)
Root caries: The challenge in today’s cariology
Tue. 30 April 2024
1:00 PM EST (New York)
Neodent Discovery: Neoarch Guided Surgery—from simple to complex cases
Fri. 3 May 2024
1:00 PM EST (New York)
Osseointegration in extrēmus: Complex maxillofacial reconstruction & rehabilitation praeteritum, praesens et futurum
Tue. 7 May 2024
8:00 PM EST (New York)
You got this! Diagnosis and management of common oral lesions
Thu. 9 May 2024
8:00 PM EST (New York)
Empowering your restorative practice: A comprehensive guide to clear aligner integration and success
Mon. 13 May 2024
9:00 AM EST (New York)
CREATING MORE PRACTICE TIME THROUGH EFFICIENCY: IMPROVED ACCURACY AND DELEGATION
Mon. 13 May 2024
1:00 PM EST (New York)
To post a reply please login or register